Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice - PubMed (original) (raw)
Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice
David J DiLillo et al. J Immunol. 2008.
Abstract
CD20 mAb-mediated B cell depletion is an effective treatment for B cell malignancies and some autoimmune diseases. However, the full effects of B cell depletion on natural, primary, and secondary Ab responses and the maintenance of Ag-specific serum Ig levels are largely unknown. The relationship between memory B cells, long-lived plasma cells, and long-lived humoral immunity also remains controversial. To address the roles of B cell subsets in the longevity of humoral responses, mature B cells were depleted in mice using CD20 mAb. Peritoneal B cell depletion reduced natural and Ag-induced IgM responses. Otherwise, CD20+ B cell depletion prevented humoral immune responses and class switching and depleted existing and adoptively transferred B cell memory. Nonetheless, B cell depletion did not affect serum Ig levels, Ag-specific Ab titers, or bone marrow Ab-secreting plasma cell numbers. Coblockade of LFA-1 and VLA-4 adhesion molecules temporarily depleted long-lived plasma cells from the bone marrow. CD20+ B cell depletion plus LFA-1/VLA-4 mAb treatment significantly prolonged Ag-specific plasma cell depletion from the bone marrow, with a significant decrease in Ag-specific serum IgG. Collectively, these results support previous claims that bone marrow plasma cells are intrinsically long-lived. Furthermore, these studies now demonstrate that mature and memory B cells are not required for maintaining bone marrow plasma cell numbers, but are required for repopulation of plasma cell-deficient bone marrow. Thereby, depleting mature and memory B cells does not have a dramatic negative effect on preexisting Ab levels.
Similar articles
- Effects of specific anti-B and/or anti-plasma cell immunotherapy on antibody production in baboons: depletion of CD20- and CD22-positive B cells does not result in significantly decreased production of anti-alphaGal antibody.
Alwayn IP, Xu Y, Basker M, Wu C, Buhler L, Lambrigts D, Treter S, Harper D, Kitamura H, Vitetta ES, Abraham S, Awwad M, White-Scharf ME, Sachs DH, Thall A, Cooper DK. Alwayn IP, et al. Xenotransplantation. 2001 Aug;8(3):157-71. doi: 10.1034/j.1399-3089.2001.008003157.x. Xenotransplantation. 2001. PMID: 11472623 - Maintenance of the plasma cell pool is independent of memory B cells.
Ahuja A, Anderson SM, Khalil A, Shlomchik MJ. Ahuja A, et al. Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4802-7. doi: 10.1073/pnas.0800555105. Epub 2008 Mar 13. Proc Natl Acad Sci U S A. 2008. PMID: 18339801 Free PMC article. - An exploratory investigation of the effect of arsenic trioxide on anti-Gal antibody production in baboons.
Gollackner B, Ryan D, Knosalla C, Basker M, Alwayn IP, Harper D, Salomon G, Mauiyyedi S, Correa L, Thall A, Cooper DK. Gollackner B, et al. Xenotransplantation. 2003 Jan;10(1):80-7. doi: 10.1034/j.1399-3089.2003.01136.x. Xenotransplantation. 2003. PMID: 12535229 - Allergy for a lifetime?
Luger EO, Wegmann M, Achatz G, Worm M, Renz H, Radbruch A. Luger EO, et al. Allergol Int. 2010 Mar;59(1):1-8. doi: 10.2332/allergolint.10-RAI-0175. Allergol Int. 2010. PMID: 20186004 Review. - The role of APRIL - A proliferation inducing ligand - In autoimmune diseases and expectations from its targeting.
Baert L, Manfroi B, Casez O, Sturm N, Huard B. Baert L, et al. J Autoimmun. 2018 Dec;95:179-190. doi: 10.1016/j.jaut.2018.10.016. Epub 2018 Oct 30. J Autoimmun. 2018. PMID: 30385081 Review.
Cited by
- Mitochondrial Pyruvate Import Promotes Long-Term Survival of Antibody-Secreting Plasma Cells.
Lam WY, Becker AM, Kennerly KM, Wong R, Curtis JD, Llufrio EM, McCommis KS, Fahrmann J, Pizzato HA, Nunley RM, Lee J, Wolfgang MJ, Patti GJ, Finck BN, Pearce EL, Bhattacharya D. Lam WY, et al. Immunity. 2016 Jul 19;45(1):60-73. doi: 10.1016/j.immuni.2016.06.011. Epub 2016 Jul 5. Immunity. 2016. PMID: 27396958 Free PMC article. - The Number of Regulatory B Cells is Increased in Mice with Collagen-induced Arthritis.
Luo L, Liu Q, Peng S, Meng Y, Du W, Luo D, Wang Q, Ding J, Dong X, Ma X. Luo L, et al. Open Life Sci. 2019 Mar 20;14:12-18. doi: 10.1515/biol-2019-0002. eCollection 2019 Jan. Open Life Sci. 2019. PMID: 33817132 Free PMC article. - Implications of rituximab pharmacokinetic and pharmacodynamic alterations in various immune-mediated glomerulopathies and potential anti-CD20 therapy alternatives.
Hartinger JM, Kratky V, Hruskova Z, Slanar O, Tesar V. Hartinger JM, et al. Front Immunol. 2022 Nov 7;13:1024068. doi: 10.3389/fimmu.2022.1024068. eCollection 2022. Front Immunol. 2022. PMID: 36420256 Free PMC article. Review. - B cell-targeted therapies for systemic lupus erythematosus: an update on clinical trial data.
Looney RJ. Looney RJ. Drugs. 2010 Mar 26;70(5):529-40. doi: 10.2165/11535420-000000000-00000. Drugs. 2010. PMID: 20297867 Review. - Perivascular Adventitial Fibroblast Specialization Accompanies T Cell Retention in the Inflamed Human Dermis.
Barron AMS, Mantero JC, Ho JD, Nazari B, Horback KL, Bhawan J, Lafyatis R, Lam C, Browning JL. Barron AMS, et al. J Immunol. 2019 Jan 1;202(1):56-68. doi: 10.4049/jimmunol.1801209. Epub 2018 Dec 3. J Immunol. 2019. PMID: 30510068 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
- AI24335/AI/NIAID NIH HHS/United States
- AI56363/AI/NIAID NIH HHS/United States
- AI67584/AI/NIAID NIH HHS/United States
- CA105001/CA/NCI NIH HHS/United States
- CA81776/CA/NCI NIH HHS/United States
- CA96547/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources